| | |
Please join Jeff Bishop LIVE today at 1pm EST for a special presentation on "How to Spot the Gamma Trigger!" | Join him here at 1pm EST in the Market Master's trading room. | Be the best prepared trader on the Street! | | FOCUS LIST🔎 | ELYM - Up over 40% in the pre-market after agreement to acquire Tenet Medicines and concurrent $120 Million Private Placement | RENT - Up over 35% in pre after reporting earnings and increased guidance | FUFU - Up over 15% in pre after reporting earnings and business update | | *sponsored by Sica Media | We have been following a small biotech company for a long time – it's a tiny stock that had a big drop, made a base for over a week and has started to break out to the upside: | Coeptis Therapeutics Holdings (COEP) | When you look at the price chart, pay attention to this Gamma Trigger reversal pattern to the upside. | | Even if you are not a professional technical analyst, this seems like a pretty easy move to spot. | It seems strange that weaker stocks sometimes have a tendency to bounce in poor market conditions. Maybe it is because short sellers cover their positions and move on to new targets? | Whatever the reason is, we think it is pretty obvious that COEP has been making a move out of the oversold zone lately. | While it is very early in the move, it may be the perfect time to start watching this again. | If this trend continues, COEP has a lot of room to run before it would even touch the levels we just saw in March. | To learn more about this opportunity, please visit this page. | As always make sure to do your full due diligence before making any investments and have a trading plan in place. | *Sponsored content/paid advertisement. This investment involves substantial risk. Please read our full disclosure below for a detailed discussion of risks and atypical results. |
|
| | HOTLIST🔥 | ELYM - Up over 40% in the pre-market after agreement to acquire Tenet Medicines and concurrent $120 Million Private Placement | Eliem Therapeutics Inc. (ELYM) is a clinical-stage biotechnology company that focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. | In the pre-market this morning, the company announced that it had made an agreement to acquire Tenet Medicines and concurrent $120 Million Private Placement. | The combined company is expected to have approximately $210 million of cash and cash equivalents. | The combined company plans to focus on advancing TNT119, a potentially best-in class anti-CD19 antibody, designed for a broad range of autoimmune diseases, including systemic lupus erythematosus, immune thrombocytopenia and membranous nephropathy. | In the private placement, Eliem has agreed to sell 31,238,282 shares of its common stock at a price of $3.84 per share, and upon the closing of the private placement, will receive aggregate gross proceeds of $120 million. | The stock traded up over 40% in the pre-market in reaction to the news. | | The $3.90 area acted as support in the pre-market and will be an important level to watch. | Above it, targets to the upside are $4.08, $4.20 and then the after-hours high at $4.55. Beyond that, $4.75 and $5.18 come into play. | Below $3.90, targets to the downside are $3.70, $3.50, $3.40, $3 and then a gap fill at $2.67. | | RENT - Up over 35% in pre after reporting earnings and increased guidance | Rent the Runway Inc. (RENT) operates a shared designer closet in the United States. The company offers evening wear and accessories, ready-to-wear, workwear, denim, casual, jewelry among other offerings. | In the after-hours yesterday, the company reported a Q4 2023 Net Loss of -$24.8million vs. -$26.2million. Q4 revenue was $75.8 million vs $75.4 million a year prior. | For fiscal year 2024, RENT expects: | Revenue growth of between 1% to 6% versus fiscal year 2023 | Adjusted EBITDA Margin of 15% to 16% | Free Cash Flow Breakeven on a full year basis | For the fiscal first quarter of 2024, Rent the Runway expects: | Revenue of between $73 million and $75 million | Adjusted EBITDA Margin of 7% to 8% | The stock traded up over 35% in the pre-market in reaction to the earnings and positive guidance. | | The $8.80 area acted as support in the pre-market and will be an important level to watch. | Above it, targets to the upside are $10.20, $11, $12, $13 and then the after-hours high at $13.95. | Below $8.80, targets to the downside are $8.10, a gap fill at $7.40 then $6.70 and $6. | | "How to Spot is the Gamma Trigger?" |
|
| Using His Custom Gamma Trigger and more than 20 years of trading experience… | Jeff Bishop has identified more than 60 triple-digit winners so far in 2024. | | Come Hear All About It TODAY @ 1pm EST |
|
| | | FUFU - Up over 15% in pre after reporting earnings and business update | BitFuFu Inc. (FUFU) provides digital asset mining and cloud mining services in Singapore. It also offers miner rental, and miner hosting and sales services to institutional customers and individual digital asset enthusiasts. | In the after-hours yesterday, FUFU reported that in 2023 total mining capacity increased 106.3% to a record 22.9 EH/s as of December 31, 2023, compared to 11.1 EH/S as of December 31, 2022. | Cloud-mining registered users increased 61.5% to 304,270 as of December 31, 2023 compared to 188,460 as of December 31, 2022 | Bitcoin ("BTC") production from self-mining operations increased 26.6% to 3,577 BTCs in 2023, from 2,825 BTCs in 2022 | Total revenue was US$284.1 million in 2023, representing an increase of 43.3% from US$198.2 million in 2022 | Net income was US$10.5 million in 2023, representing an increase of 337.5% compared with US$2.4 million in 2022 | The stock traded up over 15% in the pre-market in reaction to the earnings report and business update | | The $4.55 area acted as support in the pre-market and will be an important level to watch. | Above it, targets to the upside are $4.80, $5 and then the pre-market high at $5.35, $5.55 and $6. | Below $4.55, targets to the downside are a gap fill at $4.35, $4.20 and $4. | | MARKET NEWS 📰 | | | P.S. Make sure you text "RAGE" to (888) 404-5747 to get all of our latest HOT STOCK ideas! | | Questions or concerns about our products? Email Support@360wallstreet.io © Copyright 2022, RagingBull | | *PAID ADVERTISEMENT. Currently, RagingBull was paid twelve thousand five hundred dollars by ach bank transfer by Sica Media for advertising Coeptis from for a one day period on april 11, 2024 . RagingBull has previously been paid fifteen thousand dollars by ach bank transfer by Coeptis Therapeutics Holdings, Inc from a period beginning on December 13, 2023 through December 15 of the same year. Previously, RagingBull was paid nineteen thousand dollars by ach bank transfer by Lifewater Media for advertising Coeptis from a period beginning on June 7, 2023 through June 8 of the same year. The third party, Company, or their affiliates may own and likely wish to liquidate shares of the Company at or near the time you receive this advertisement, which has the potential to hurt share prices. This advertisement and other marketing efforts, including alerts, may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Coeptis Therapeutics Holdings, Inc, increased trading volume, and possibly an increased share price of Coeptis Therapeutics Holdings, Inc's securities, which may or may not be temporary and decrease once the marketing arrangement has ended. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of the issuance of this advertisement, the owners of Raging Bull do not hold a position in Coeptis Therapeutics Holdings, Inc, though they reserve the right to buy or sell shares in the covered company at any time following the dissemination of this communication. | SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. | Our reports/releases are a commercial advertisement and are for general information purposes ONLY. A portion of our business is engaged in the marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. A portion of RagingBull's business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, SMS, push notifications. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the corporate awareness program ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. | TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. | NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is not currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. | USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as "believes," "anticipates," "estimates," "expects," "projects," "intends," or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https: // www. Sec. gov/ edgar/searchedgar /companysearch | FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company's financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. | WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers mentioned in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. | RagingBull.com, LLC shall be entitled to recover attorneys' fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys' fees, costs and disbursements in addition to any other relief to which it may be entitled. |
|
| |
|
Post a Comment
Post a Comment